VTE Risk Assessment in Pregnancy

Overview

Journal Res Pract Thromb Haemost

Publisher Elsevier

Date 2020 Feb 29

PMID 32110748

Citations 12

Authors

Karl Ewins

Fionnuala Ni Ainle

Affiliations

Soon will be listed here.

Abstract

A State of the Art lecture, "VTE Risk Assessment in Pregnancy," was presented at the ISTH congress in Melbourne, Australia, in 2019. Venous thromboembolism (VTE) remains a leading cause of death in pregnancy and in the postpartum period. Moreover, VTE can result in lifelong disability. The elevated baseline pregnancy-associated VTE risk is further increased by additional maternal, pregnancy, and delivery characteristics, highlighting the importance of VTE risk assessment in early pregnancy, at delivery, and if risk factors change. This review will provide an overview of the impact and epidemiology of VTE in pregnancy (including reported risk factors for pregnancy-associated VTE), will address VTE risk-reduction strategies (including ongoing studies), and will provide a summary of critical knowledge gaps. Finally, throughout this review, relevant new data presented during the 2019 ISTH annual congress in Melbourne will be summarized.

Citing Articles

Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum.

Li Q, Wang H, Wang H, Deng J, Cheng Z, Fan F MedComm (2020). 2024; 5(7):e619.

PMID: 38938286 PMC: 11208741. DOI: 10.1002/mco2.619.

Combining gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study.

Xu D, He Y, Liao C, Tan J Biomed Rep. 2024; 20(6):96.

PMID: 38765860 PMC: 11099602. DOI: 10.3892/br.2024.1784.

Prevention, diagnosis, and management of PE and DVT in pregnant women.

Kevane B, Ainle F Hematology Am Soc Hematol Educ Program. 2023; 2023(1):237-247.

PMID: 38066865 PMC: 10727078. DOI: 10.1182/hematology.2023000476.

Association between serum alkaline phosphatase levels in late pregnancy and the incidence of venous thromboembolism postpartum: a retrospective cohort study.

Li Q, Wang H, Wang H, Deng J, Cheng Z, Lin W EClinicalMedicine. 2023; 62:102088.

PMID: 37533415 PMC: 10393549. DOI: 10.1016/j.eclinm.2023.102088.

Monitoring medicine prescriptions before, during and after pregnancy in Italy.

Fortinguerra F, Belleudi V, Poggi F, Perna S, Bortolus R, Donati S PLoS One. 2023; 18(6):e0287111.

PMID: 37319236 PMC: 10270638. DOI: 10.1371/journal.pone.0287111.

References

Brill-Edwards P, Ginsberg J, Gent M, Hirsh J, Burrows R, Kearon C . Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000; 343(20):1439-44. DOI: 10.1056/NEJM200011163432002. View

Kotaska A . Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens. BJOG. 2018; 125(9):1109-1116. PMC: 6055738. DOI: 10.1111/1471-0528.15150. View

Liu S, Rouleau J, Joseph K, Sauve R, Liston R, Young D . Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can. 2009; 31(7):611-620. DOI: 10.1016/S1701-2163(16)34240-2. View

Ewins K, Ainle F . VTE risk assessment in pregnancy. Res Pract Thromb Haemost. 2020; 4(2):183-192. PMC: 7040539. DOI: 10.1002/rth2.12290. View

. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstet Gynecol. 2018; 132(1):e1-e17. DOI: 10.1097/AOG.0000000000002706. View

McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S . Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol. 2011; 52(1):3-13. DOI: 10.1111/j.1479-828X.2011.01357.x. View

Rodger M, Phillips P, Kahn S, James A, Konkle B . Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial. Thromb Haemost. 2014; 113(1):212-6. DOI: 10.1160/TH14-06-0485. View

Morrison R, Crawford J, MacPherson M, Heptinstall S . Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb Haemost. 1985; 54(3):607-11. View

De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannucci P . The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006; 135(3):386-91. DOI: 10.1111/j.1365-2141.2006.06317.x. View

10.

. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol. 2011; 118(3):718-729. DOI: 10.1097/AOG.0b013e3182310c4c. View

11.

Chan W, Kent N, Rey E, Corbett T, David M, Douglas M . Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014; 36(6):527-53. DOI: 10.1016/s1701-2163(15)30569-7. View

12.

Arya R . Postpartum venous thromboembolism prophylaxis: harm versus benefit. BJOG. 2018; 125(9):1117. DOI: 10.1111/1471-0528.15182. View

13.

Gerhardt A, Scharf R, Greer I, Zotz R . Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium. Blood. 2016; 128(19):2343-2349. PMC: 5813719. DOI: 10.1182/blood-2016-03-703728. View

14.

OShaughnessy F, Donnelly J, Cooley S, Deering M, Raman A, Gannon G . Thrombocalc: implementation and uptake of personalized postpartum venous thromboembolism risk assessment in a high-throughput obstetric environment. Acta Obstet Gynecol Scand. 2017; 96(11):1382-1390. DOI: 10.1111/aogs.13206. View

15.

Bain E, Wilson A, Tooher R, Gates S, Davis L, Middleton P . Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014; (2):CD001689. DOI: 10.1002/14651858.CD001689.pub3. View

16.

Abdul Sultan A, West J, Grainge M, Riley R, Tata L, Stephansson O . Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study. BMJ. 2016; 355:i6253. PMC: 5137302. DOI: 10.1136/bmj.i6253. View

17.

Cox S, Eslick R, McLintock C . Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism. J Thromb Haemost. 2019; 17(7):1160-1170. DOI: 10.1111/jth.14452. View

18.

Lindqvist P, Dahlback B, Marsal K . Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999; 94(4):595-9. DOI: 10.1016/s0029-7844(99)00308-7. View

19.

Rodger M . Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification. Hematology Am Soc Hematol Educ Program. 2015; 2014(1):387-92. DOI: 10.1182/asheducation-2014.1.387. View

20.

Tardy B, Richardson J, Nithipipat V, Kempe K, Guo J, Cho K . Protein Adsorption and Coordination-Based End-Tethering of Functional Polymers on Metal-Phenolic Network Films. Biomacromolecules. 2019; 20(3):1421-1428. DOI: 10.1021/acs.biomac.9b00006. View